Neupogen Amgen 30
Neupogen Amgen 30 is a medicine authorised by Swissmedic under authorisation number 51035. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 October 1991 and the authorisation is valid without a time limit. ATC code L03AA02 places the medicine in the group Immunostimulants.
| Authorisation number | 51035 |
|---|---|
| Name | Neupogen Amgen 30 |
| Full name | Neupogen Amgen 30, Injektionslösung |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L03AA02 |
| First authorisation | 11 October 1991 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Neupogen Amgen 30, Injektionslösung | A | 11 October 1991 |
| 6 | Neupogen Amgen 30, Injektionslösung in einer Fertigspritze | A | 27 November 1998 |
| 7 | Neupogen Amgen 48, Injektionslösung in einer Fertigspritze | A | 27 November 1998 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 143 | 5 x 1 mL | Durchstechflasche(n) | L03AA02 | 06.07.3. | A |
| 186 | 5 x 0.5 mL | Spritze(n) | L03AA02 | 06.07.3. | A |
| 208 | 5 x 0.5 mL | Spritze(n) | L03AA02 | 06.07.3. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Neupogen Amgen 30 authorised in Switzerland?
Yes. Neupogen Amgen 30 is authorised by Swissmedic under authorisation number 51035, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Neupogen Amgen 30 have?
Neupogen Amgen 30 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Neupogen Amgen 30?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.